CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol
DOI: 10.1055/s-0042-1742614
Case Report with Review of Literature

Bilateral CMV Retinitis in a Patient with Relapsed Non-Hodgkin Lymphoma on Oral Metronomic Chemotherapy: Case Report and Review of Literature

Fen Saj
1   Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
,
Amit Kumar Deb
2   Department of Ophthalmology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
,
Subhashini Kaliaperumal
2   Department of Ophthalmology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
,
Smita Kayal
1   Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
,
1   Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
,
Rahul Dhodapkar
3   Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
,
1   Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India
› Author Affiliations
Funding None.

Abstract

Cytomegalovirus (CMV) retinitis is one of the common complications in profoundly immunosuppressed patients such as those with acquired immune deficiency syndrome. It has been rarely reported in patients with lymphoma on aggressive chemotherapy. We encountered a patient with bilateral CMV retinitis who developed this vision-threatening complication while on low-dose palliative metronomic chemotherapy with oral drugs (cyclophosphamide, procarbazine, etoposide, and prednisolone). Though the infection resolved with treatment, there was residual vision loss. This case is presented to sensitize clinicians to the possibility of unusual infections in patients on long-term oral chemotherapies.

Declaration of Patient Consent

The authors certify that they have obtained all appropriate patient consent forms.




Publication History

Article published online:
26 April 2022

© 2022. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Santos KD, Lien K, Georgsdottir S, Sivanathan L, Emmenegger U. Adverse side effects associated with the use of low-dose metronomic chemotherapy. In: Bocci G, Francia G. eds. Metronomic Chemotherapy: Pharmacology and Clinical Applications. Berlin, Heidelberg: Springer; 2014: 263-279
  • 2 Coleman M, Martin P, Ruan J. et al. Low-dose metronomic, multidrug therapy with the PEP-C oral combination chemotherapy regimen for mantle cell lymphoma. Leuk Lymphoma 2008; 49 (03) 447-450
  • 3 Guembel HO, Ohrloff C. Opportunistic infections of the eye in immunocompromised patients. Ophthalmologica 1997; 211 (Suppl. 01) 53-61
  • 4 Brown SM, Jampol LM, Cantrill HL. Intraocular lymphoma presenting as retinal vasculitis. Surv Ophthalmol 1994; 39 (02) 133-140
  • 5 Tang L-J, Gu C-L, Zhang P. Intraocular lymphoma. Int J Ophthalmol 2017; 10 (08) 1301-1307
  • 6 Dhillon B. The management of cytomegalovirus retinitis in AIDS. Br J Ophthalmol 1994; 78 (01) 66-69
  • 7 Azevedo LS, Pierrotti LC, Abdala E. et al. Cytomegalovirus infection in transplant recipients. Clinics (São Paulo) 2015; 70 (07) 515-523
  • 8 Chakravarti A, Kashyap B, Matlani M. Cytomegalovirus infection: an Indian perspective. Indian J Med Microbiol 2009; 27 (01) 3-11
  • 9 Shibata D, Martin WJ, Appleman MD, Causey DM, Leedom JM, Arnheim N. Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis 1988; 158 (06) 1185-1192
  • 10 Salmon D, Lacassin F, Harzic M. et al. Predictive value of cytomegalovirus viraemia for the occurrence of CMV organ involvement in AIDS. J Med Virol 1990; 32 (03) 160-163
  • 11 Fox GM, Crouse CA, Chuang EL. et al. Detection of herpesvirus DNA in vitreous and aqueous specimens by the polymerase chain reaction. Arch Ophthalmol 1991; 109 (02) 266-271
  • 12 Mitchell SM, Fox JD, Tedder RS, Gazzard BG, Lightman S. Vitreous fluid sampling and viral genome detection for the diagnosis of viral retinitis in patients with AIDS. J Med Virol 1994; 43 (04) 336-340
  • 13 Jabs DA, Ahuja A, Van Natta M, Dunn JP, Yeh S. Studies of the Ocular Complications of AIDS Research Group. Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology 2013; 120 (06) 1262-1270
  • 14 Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H. et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep 2009; 58: 1-207 ; quiz CE1–4
  • 15 Smith ME. Retinal involvement in adult cytomegalic inclusion disease. Arch Ophthalmol 1964; 72 (72) 44-49
  • 16 Nasir MA, Jaffe GJ. Cytomegalovirus retinitis associated with Hodgkin's disease. Retina 1996; 16 (04) 324-327
  • 17 Toy JL, Knowlden RP. Cytomegalovirus retinitis misdiagnosed as Hodgkin's lymphoma deposits. BMJ 1978; 2 (6149): 1398-1399
  • 18 Tudesq J-J, Vincent L, Lebrun J. et al. Cytomegalovirus infection with retinitis after brentuximab vedotin treatment for CD30+ lymphoma. Open Forum Infect Dis 2017; 4 (02) ofx091
  • 19 Tyagi M, Ambiya V, Mathai A, Narayanan R. Atypical cytomegalovirus retinitis in non-Hodgkin's lymphoma. BMJ Case Rep. 2015. Accessed June 17, 2021 at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533632/
  • 20 Kang HM. Cytomegalovirus retinitis in patients with diffuse large B-cell lymphoma. J. Retin 2017; 2: 97-100
  • 21 Kawai Y, Kawai R, Nakayama T. et al. Successful treatment of cytomegalovirus retinitis in a patient with malignant lymphoma: a case report and review of the literature. Int J Hematol 1999; 69 (04) 256-259
  • 22 Chawla R, Venkatesh P, Garg SP, Mandal S, Tewari HK. Cytomegalovirus retinitis in a patient with non-Hodgkins lymphoma: a diagnostic dilemma. Eur J Ophthalmol 2005; 15 (01) 153-157
  • 23 Akpek EK, Kent C, Jakobiec F, Caliendo AM, Foster CS. Bilateral acute retinal necrosis caused by cytomegalovirus in an immunocompromised patient. Am J Ophthalmol 1999; 127 (01) 93-95
  • 24 Vote B, Russell M, Polkinghorne P. Recurrent cytomegalovirus retinitis in a patient with a normal lymphocyte count who had undergone splenectomy for lymphoma. Retina 2005; 25 (02) 220-221
  • 25 Derzko-Dzulynsky LA, Berger AR, Berinstein NL. Cytomegalovirus retinitis and low-grade non-Hodgkin's lymphoma: case report and review of the literature. Am J Hematol 1998; 57 (03) 228-232
  • 26 Reddy S, Tyagi M, Behera S. et al. Cytomegalovirus retinitis in patients of non-Hodgkin's lymphoma: clinical presentations and outcomes. J Ophthalmic Inflamm Infect 2021; 11 (01) 26